In the News

How Ivor Horn Blends Technology with a Human Touch

Ivor Horn, chief medical officer at Accolade, knows what it’s like to feel lost in the maze of healthcare. When she was a child, her father experienced a traumatic brain injury—opening her eyes to just how complex and disempowering patient-provider interactions can be. But the struggle to know who to ask questions,...

SHYFT Analytics to be acquired by New York company

Waltham, Massachusetts-based SHYFT Analytics has agreed to be acquired by New York technology company Medidata. The deal is valued at $195 million, and Medidata says it will help to increase its growth in Massachusetts. SHYFT is a private company that manages data for pharmaceutical, biotech, and medical device...

Medidata Defines the Future of Life Sciences with Acquisition of SHYFT Analytics

Medidata announced on June 12 that it will acquire SHYFT Analytics for a total consideration of $195 million. The acquisition is subject to customary closing adjustments, is inclusive of Medidata’s prior 6% ownership in SHYFT’s business, and will be paid in cash. “Together, Medidata and SHYFT are powering customers’...

Propeller Health Raises Strategic Investment from McKesson Ventures

Propeller Health announced today that McKesson Ventures has contributed an undisclosed amount to its $20 million strategic funding round. The funding will allow Propeller Health to continue developing connected medicines for the treatment of chronic respiratory disease and expand into additional therapeutic areas....

How do people living with dementia make assistive technology work for them?

Over the past 10 years, a lot of consideration has been given to how technology can be used to help care for people living with dementia. Voice recognition systems such as the Amazon Echo will never tire of repeated inquiries about the date and time.  This interactive technology can also be used to provide prompts...

New Test May Detect Lung Cancer Early, But It Is Still a Long Way Off

At last weekend’s American Society of Clinical Oncology annual meeting, GRAIL released results of a study that shows the potential for lung cancer to be detected with a blood test. The survey evaluated 127 patients with lung cancer and 580 controls. The researchers found that more than 50 percent of the mutations...

Press Releases

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.